Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

George A. Makar, M.D., M.S.C.E.

George A. Makar, M.D., M.S.C.E.

faculty photo
Assistant Professor of Clinical Medicine
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-8559
Education:
BS (Pharmacy)
Drake University, Des Moines, IA, 1995.
MD
University of Iowa College of Medicine, 2000.
MSCE
University of Pennsylvania School of Medicine, 2009.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Selected Publications

Makar GA, Holmes JH, Yang YX. : Angiotensin-Converting Enzyme Inhibitor Therapy and Colorectal Cancer Risk. J Natl Cancer Inst 2014.

Goldberg DS, Makar G, Bittermann T, French B. : Center variation in the use of nonstandardized model for end-stage liver disease exception points. Liver Transpl 2013.

Robert Weinrieb, Omair Abbasi, Marlee Madora, Alexandra Leto, Kevin Lynch, George Makar : A Matched Comparison Study of Medical and Psychiatric Complications in Methadone-Maintained Liver Transplant Recipients: Re-evaluation Nine Years Later Academy of Psychosomatic Medicine, 60th Annual Meeting. 2013 Notes: oral presentation.

Cantor JP, Makar GA, Reddy KR, Furth EE: Hepatic Injury in the Liver Allograft Biopsy Continues Despite Hepatitis C Viral Clearance with Interferon Treatment. United States and Canadian Academy of Pathology Annual Meeting 2012 2012 Notes: Poster Presentation.

McConnell RA, Kim S, Ahmad NA, Falk GW, Forde KA, Ginsberg GG, Jaffe DL, Makar GA, Long WB, Panganamamula KV, Kochman ML. : Poor Discriminatory Function for Endoscopic Skills on a Computer-Based Simulator. Gastrointest Endosc 76: 993-1002, 2012.

Bittermann T, Makar G, Goldberg D. : Exception point applications for 15 points for liver transplantation: An unintended consequence of the Share 15 policy. American Association of Study of Liver Disease Annual Meeting 2012 2012 Notes: Oral Presentation.

Bittermann T, Makar G, Goldberg D. : Exception point applications for 15 points: an unintended consequence of the share 15 policy. Liver Transpl 18:: 1302-9, 2012 Notes: Oral Presentation.

Goldberg D, Bittermann T, Makar G: Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis. Am J Transplant 12: 1603-9, 2012.

Mendizabal M, Reddy KR, Cassuto J, Olthoff KM, Faust TW, Makar GA, Rand EB, Shaked A, Abt PL. : Liver transplantation in patients with cystic fibrosis: Analysis of united network for organ sharing data. Liver Transpl 17: 243-50, 2011.

Tsai DE, Hagemann IS, Morrissette JJ, Daber R, Xu D, Schuster SJ, Bloom RD, Ahya VN, Jessup M, Makar GA, Chen S, Reshef R. : Allograft vs non-allograft posttransplant lymphoproliferative disorder, characterization of 2 distinct subtypes as defined by presentation, histology, and outcome: a case series of 165 patients. American Society of Clinical Oncology (ASCO) Annual Meeting 2011. 2011 Notes: Oral Presentation.

back to top
Last updated: 08/22/2014
The Trustees of the University of Pennsylvania